Adipocyte iron regulates leptin and food intake

Journal of Clinical Investigation

Volumn 125, Issue 9, 2015, Pages 3681-3691

  Gao, Yan ^a,b   Li, Zhonggang ^a   Scott Gabrielsen, J ^a   Simcox, Judith A ^a   Lee, Soh Hyun ^a   Jones, Deborah ^a   Cooksey, Bob ^a,c   Stoddard, Gregory ^a   Cefalu, William T ^d   McClain, Donald A ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ACUTE PHASE PROTEIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; FERRITIN; FERROPORTIN; HEPCIDIN; IRON; LEPTIN; MESSENGER RNA; CREB1 PROTEIN, MOUSE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN;

ADIPOCYTE; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; CELL LOSS; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; FOOD INTAKE; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; HUMAN; IRON INTAKE; IRON OVERLOAD; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; 3T3 CELL LINE; ANIMAL; DIET SUPPLEMENTATION; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; EATING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MORTALITY; MUTANT MOUSE STRAIN; PATHOPHYSIOLOGY;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIETARY SUPPLEMENTS; EATING; FERRITINS; GENE EXPRESSION REGULATION; HEMOCHROMATOSIS; IRON; LEPTIN; MICE; MICE, MUTANT STRAINS; RESPONSE ELEMENTS;

EID: 84941662342     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI81860     Document Type: Article

References (59)

1. Lynch SR. Why nutritional iron deficiency persists as a worldwide problem. J Nutr. 2011;141(4):763S-768S.
2. Lawless JW, Latham MC, Stephenson LS, Kinoti SN, Pertet AM. Iron supplementation improves appetite and growth in anemic Kenyan primary school children. J Nutr. 1994;124(5):645-654.
3. Stoltzfus RJ, et al. Low dose daily iron supplementation improves iron status and appetite but not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and anemia in Zanzibari preschool children. J Nutr. 2004;134(2):348-356.
4. Seltzer CC, Mayer J. Serum iron and iron-binding capacity in adolescents. II. comparison of obese and nonobese subjects. Am J Clin Nutr. 1963;13:354-361.
5. Gillum RF. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men-The Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord. 2001;25(5):639-645.
6. Moayeri H, Bidad K, Zadhoush S, Gholami N, Anari S. Increasing prevalence of iron deficiency in overweight and obese children and adolescents (Tehran Adolescent Obesity Study). Eur J Pediatr. 2006;165(11):813-814.
7. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweight children and adolescents: A risk group for iron deficiency. Pediatrics. 2004;114(1):104-108.
8. Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Lilos P, Phillip M. Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord. 2003;27(3):416-418.
9. Dongiovanni P, et al. Dietary iron overload induces visceral adipose tissue insulin resistance. Am J Pathol. 2013;182(6):2254-2263.
10. Shahramian I, Akhlaghi E, Ramezani A, Rezaee A, Noori N, Sharafi E. A study of leptin serum concentrations in patients with major beta-Thalassemia. Iran J Ped Hematol Oncol. 2013;3(2):59-63.
11. Karachaliou F, Vlachopapadopoulou E, Theochari M, Konstandellou E, Michalados S. Leptin levels in patients with thalassemia major. Minerva Pediatr. 2006;58(4):373-378.
12. Choobineh H, et al. Evaluation of leptin levels in major beta-Thalassemic patients. Int J Hematol Oncol Stem Cell Res. 2009;3(4):1-4.
13. Miraglia Del Giudice E, et al. Evaluation of leptin protein levels in patients with Cooleys anaemia. Br J Haematol. 1999;105(3):839-840.
14. Dedoussis GV, Kyrtsonis MC, Andrikopoulos NE, Voskaridou E, Loutradis A. Inverse correlation of plasma leptin and soluble transferrin receptor levels in β-Thalassemia patients. Ann Hematol. 2002;81(9):543-547.
15. Topaloglu AK, Hallioglu O, Canim A, Duzovali O, Yilgor E. Lack of association between plasma leptin levels and appetite in children with iron deficiency. Nutrition. 2001;17(7-8):657-659.
16. Stull AJ, Galgani JE, Johnson WD, Cefalu WT. The contribution of race and diabetes status to metabolic flexibility in humans. Metabolism. 2010;59(9):1358-1364.
17. Fleming DJ, et al. Iron status of the free-living, elderly Framingham Heart Study cohort: An iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr. 2001;73(3):638-646.
18. Nelson R, Chawla M, Connolly P, LaPorte J. Ferritin as an index of bone marrow iron stores. South Med J. 1978;71(12):1482-1484.
19. Cook JD, Lipschitz DA, Miles LE, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr. 1974;27(7):681-687.
20. Gabrielsen JS, et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest. 2012;122(10):3529-3540.
21. Wilson C. Metabolism: iron metabolism, adiponectin and T2DM-The link with adipocyte insulin resistance. Nat Rev Endocrinol. 2012;8(12):696.
22. Milman N, Graudal N, Hegnhoj J, Christoffersen P, Pedersen NS. Relationships among serum iron status markers, chemical and histochemical liver iron content in 117 patients with alcoholic and non-Alcoholic hepatic disease. Hepatogastroenterology. 1994;41(1):20-24.
23. Casey JL, et al. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science. 1988;240(4854):924-928.
24. Donovan A, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005;1(3):191-200.
25. Eguchi J, et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metab. 2011;13(3):249-259.
26. Furuhashi M, Fucho R, Gorgun CZ, Tuncman G, Cao H, Hotamisligil GS. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest. 2008;118(7):2640-2650.
27. He W, et al. Adipose-specific peroxisome proliferator-Activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A. 2003;100(26):15712-15717.
28. Cole BK, Morris MA, Grzesik WJ, Leone KA, Nadler JL. Adipose tissue-specific deletion of 12/15-lipoxygenase protects mice from the consequences of a high-fat diet. Mediators Inflamm. 2012;2012:851798.
29. Ross CE, Muir WA, Alan BP, Graham RC, Kellermeyer RW. Hemochromatosis. Pathophysiologic and genetic considerations. Am J Clin Pathol. 1975;63(2):179-191.
30. Cairo G, Recalcati S, Montosi G, Castrusini E, Conte D, Pietrangelo A. Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood. 1997;89(7):2546-2553.
31. Zeigerer A, Rodeheffer MS, McGraw TE, Friedman JM. Insulin regulates leptin secretion from 3T3-L1 adipocytes by a PI 3 kinase independent mechanism. Exp Cell Res. 2008;314(11-12):2249-2256.
32. Gong DW, Bi S, Pratley RE, Weintraub BD. Genomic structure and promoter analysis of the human obese gene. J Biol Chem. 1996;271(8):3971-3974.
33. Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD, Vinson C. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol Cell Biol. 1998;18(2):967-977.
34. Sassone-Corsi P, Ransone LJ, Verma IM. Crosstalk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements. Oncogene. 1990;5(3):427-431.
35. Hai T, Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci U S A. 1991;88(9):3720-3724.
36. Manna PR, Stocco DM. Crosstalk of CREB and Fos/Jun on a single cis-element: Transcriptional repression of the steroidogenic acute regulatory protein gene. J Mol Endocrinol. 2007;39(4):261-277.
37. Fink JS, Verhave M, Kasper S, Tsukada T, Mandel G, Goodman RH. The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMPregulated enhancer. Proc Natl Acad Sci U S A. 1988;85(18):6662-6666.
38. Sassone-Corsi P. Cyclic AMP induction of early adenovirus promoters involves sequences required for E1A trans-Activation. Proc Natl Acad Sci U S A. 1988;85(19):7192-7196.
39. Nichols M, et al. Phosphorylation of CREB affects its binding to high and low affinity sites: implications for cAMP induced gene transcription. EMBO J. 1992;11(9):3337-3346.
40. Bothwell TH, Charlton RW. A general approach to the problems of iron deficiency and iron overload in the population at large. Semin Hematol. 1982;19(1):54-67.
41. Cook JD, Skikne BS, Lynch SR, Reusser ME. Estimates of iron sufficiency in the US population. Blood. 1986;68(3):726-731.
42. Farooqi IS, Bullmore E, Keogh J, Gillard J, ORahilly S, Fletcher PC. Leptin regulates striatal regions and human eating behavior. Science. 2007;317(5843):1355.
43. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395(6704):763-770.
44. Simcox JA, et al. Dietary iron controls circadian hepatic glucose metabolism through heme synthesis. Diabetes. 2014;64(4):1108-1119.
45. Moller N, OBrien P, Nair KS. Disruption of the relationship between fat content and leptin levels with aging in humans. J Clin Endocrinol Metab. 1998;83(3):931-934.
46. Lee MJ, Wu Y, Fried SK. Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med. 2013;34(1):1-11.
47. Hausman GJ, Hausman DB. Search for the preadipocyte progenitor cell. J Clin Invest. 2006;116(12):3103-3106.
48. Fried SK, Ricci MR, Russell CD, Laferrere B. Regulation of leptin production in humans. J Nutr. 2000;130(12):3127S-3131S.
49. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature. 1998;393(6686):684-688.
50. Altarejos JY, Montminy M. CREB and the CRTC co-Activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol. 2011;12(3):141-151.
51. Yang DC, et al. cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS One. 2008;3(2):e1540.
52. Rexach JE, Clark PM, Mason DE, Neve RL, Peters EC, Hsieh-Wilson LC. Dynamic O-GlcNAc modification regulates CREB-mediated gene expression and memory formation. Nat Chem Biol. 2012;8(3):253-261.
53. McClain DA, et al. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci U S A. 2002;99(16):10695-10699.
54. Zhou XY, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A. 1998;95(5):2492-2497.
55. Birsoy K, et al. Cellular program controlling the recovery of adipose tissue mass: An in vivo imaging approach. Proc Natl Acad Sci U S A. 2008;105(35):12985-12990.
56. Chen Z, Torrens JI, Anand A, Spiegelman BM, Friedman JM. Krox20 stimulates adipogenesis via C/EBPbeta-dependent and-independent mechanisms. Cell Metab. 2005;1(2):93-106.
57. Huang J, et al. Increased glucose disposal and AMP-dependent kinase signaling in a mouse model of hemochromatosis. J Biol Chem. 2007;282(52):37501-37507.
58. Chakrabarti P, Kandror KV. FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes. J Biol Chem. 2009;284(20):13296-13300.
59. Adams TD, et al. Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity (Silver Spring). 2010;18(1):121-130.